(Q40314287)

English

Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study

scientific article published on 10 November 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

object named as

Oscar H Franco

9

0 references

5

object named as

Albert Hofman

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Bruno H Stricker

6

object named as

Bruno H C Stricker

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

object named as

Maryam Kavousi

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

object named as

Symen Ligthart

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Thijs T W van Herpt

2

object named as

Thijs T W van Herpt

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Maarten J. G. Leening

3

object named as

Maarten J G Leening

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Mandy van Hoek

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

10 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

44-51

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediabetes: a high-risk state for diabetes development.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifetime risk of developing coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The lifetime risk of developing breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifetime Risk for Diabetes Mellitus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985-2011: a modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lifetime risk and projected population prevalence of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Rotterdam Study: 2014 objectives and design update

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The standard error of an estimate of expectation of life, with special reference to expectation of tumourless life in experiments with mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of BMI on lifetime risk for diabetes in the U.S

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Healthy Volunteer Effect and Cardiovascular Risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900362-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S2213-8587(15)00362-9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40314287&oldid=1895014663"